Mark P Rubinstein, PhD Ohio State cancer researcher

Mark P Rubinstein, PhD, is a Translational Therapeutics research program member at the OSUCCC – James. Learn more

Mark P. Rubinstein's research works

UNC researchers help create key diagnostic measures for

Immunotherapeutic HCW9218 augments anti-tumor activity of

Sad News - Mark Rubinstein Passes Away - The American Finance

Immunotherapeutic HCW9218 augments anti-tumor activity of

Transformations in Nursing & Health

Summer2015pdfwithcopyoncover

Immunotherapeutic HCW9218 augments anti-tumor activity of

Immunotherapy: Programming Your Immune System to Target Cancer

Jensen and Colleagues Identify Underlying Causes of Cardiotoxicity

Ramesh Tailor MD Anderson Cancer Center

Cancers, Free Full-Text

Mark P. Rubinstein's research works